Dopamine D1 and D2 receptor selectivities of phenyl-benzazepines in rhesus monkey striata

被引:17
作者
Weed, MR [1 ]
Woolverton, WL [1 ]
Paul, IA [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Psychiat & Human Behav, Jackson, MS 39216 USA
关键词
dopamine; dopamine receptor agonist; dopamine receptor antagonist; (rhesus monkey); (rat); radioligand binding; SCH; 23390; spiperone; phenyl-benzazepine;
D O I
10.1016/S0014-2999(98)00669-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several phenyl-benzazepine compounds, putatively selective dopanzine D-1 receptor agonists, have been used to study the effects of dopamine D-1 receptor stimulation in rodents and nonhuman primates. However, the dopamine receptor selectivities of these compounds have not been established in nonhuman primates. Accordingly, the relative selectivities of six phenyl-benzazepines for dopamine D-1-like and D-2-like receptors were assessed in rhesus monkey and, for comparison, rat striata. The compounds tested had higher affinity for D-1 than D-2 receptors in both species; however, their selectivity varied by up to three orders of magnitude. GTP (100 mu M) reduced agonist binding at the high-affinity state of the dopamine D-1 receptor, but the magnitude of the effect of CTP did not reliably predict a compound's efficacy. Furthermore, a history of cocaine self-administration did not appear to influence dopamine receptor binding characteristics in the rhesus monkeys in this study. The present results will aid the comparison of dopamine receptor binding characteristics and behavioral effects of D-1 dopamine receptor agonists. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:129 / 142
页数:14
相关论文
共 37 条
[1]   DOPAMINE RECEPTOR AGONISTS - SELECTIVITY AND DOPAMINE-D1 RECEPTOR EFFICACY [J].
ANDERSEN, PH ;
JANSEN, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (06) :335-347
[2]   RELATIVE DOPAMINE D1 AND D2 RECEPTOR AFFINITY AND EFFICACY DETERMINE WHETHER DOPAMINE AGONISTS INDUCE HYPERACTIVITY OR ORAL STEREOTYPY IN RATS [J].
ARNT, J ;
BOGESO, KP ;
HYTTEL, J ;
MEIER, E .
PHARMACOLOGY & TOXICOLOGY, 1988, 62 (03) :121-130
[3]   DOPAMINERGIC INNERVATION OF THE CEREBRAL-CORTEX - UNEXPECTED DIFFERENCES BETWEEN RODENTS AND PRIMATES [J].
BERGER, B ;
GASPAR, P ;
VERNEY, C .
TRENDS IN NEUROSCIENCES, 1991, 14 (01) :21-27
[4]  
Bergman J, 1996, J PHARMACOL EXP THER, V276, P942
[5]  
CHABERT C, 1994, J NEUROCHEM, V63, P62
[6]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]   THE DOPAMINE D1D RECEPTOR - CLONING AND CHARACTERIZATION OF 3 PHARMACOLOGICALLY DISTINCT D1-LIKE RECEPTORS FROM GALLUS-DOMESTICUS [J].
DEMCHYSHYN, LL ;
SUGAMORI, KS ;
LEE, FJS ;
HAMADANIZADEH, SA ;
NIZNIK, HB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :4005-4012
[8]   EFFECTS OF REPEATED INJECTIONS OF COCAINE ON CATECHOLAMINE RECEPTOR-BINDING SITES, DOPAMINE TRANSPORTER BINDING-SITES AND BEHAVIOR IN RHESUS-MONKEY [J].
FARFEL, GM ;
KLEVEN, MS ;
WOOLVERTON, WL ;
SEIDEN, LS ;
PERRY, BD .
BRAIN RESEARCH, 1992, 578 (1-2) :235-243
[9]   Pharmacological analysis of dopamine stimulation of [S-35]-GTP gamma S binding via human D-2short and D-2long dopamine receptors expressed in recombinant cells [J].
Gardner, B ;
Hall, DA ;
Strange, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1544-1550
[10]   FULL DOPAMINE D-1 AGONISTS IN HUMAN CAUDATE - BIOCHEMICAL-PROPERTIES AND THERAPEUTIC IMPLICATIONS [J].
GILMORE, JH ;
WATTS, VJ ;
LAWLER, CP ;
NOLL, EP ;
NICHOLS, DE ;
MAILMAN, RB .
NEUROPHARMACOLOGY, 1995, 34 (05) :481-488